INBRIJA

levodopa inhalation powder · Acorda Therapeutics

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for INBRIJA, covering 2018-12-21 to 2026-03-31. Get the full timeline:

Most recent: FDA Approved: INBRIJA — Supplemental Application (Merz Pharmaceuticals, LLC)